The Go-To CDMO for Your Most Challenging Biological Drug Product

The experience, capacity, and determination to go the distance

Fast Facts: Emergent's CDMO Division


Traditional & Emerging: Mammalian, plasma proteins
Next-Gen Therapies: mRNA,  nanoparticle platforms 

CDMO Development & Manufacturing Facilities


Industries Served

Emerging and virtual pharma and biotechs
Established small, mid-sized, and large pharma 
Government & non-government research organizations


end-to-end biologics manufacturing and scale-up support, including development services, drug substance and drug product/packaging, analytical and quality testing services

Product Lifestyle Support

All phases — Pre-clinical development through commercialization

Let’s Start A Conversation

Connect now